US3835845A - Cardiac synchronization system and method - Google Patents

Cardiac synchronization system and method Download PDF

Info

Publication number
US3835845A
US3835845A US00300290A US30029072A US3835845A US 3835845 A US3835845 A US 3835845A US 00300290 A US00300290 A US 00300290A US 30029072 A US30029072 A US 30029072A US 3835845 A US3835845 A US 3835845A
Authority
US
United States
Prior art keywords
waveform
trace
signal
arterial
marker
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
US00300290A
Inventor
C Maher
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Intermedics Cardiassist Corp
MEDICAL INNOVATIONS Inc
Original Assignee
MEDICAL INNOVATIONS Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US00300290A priority Critical patent/US3835845A/en
Application filed by MEDICAL INNOVATIONS Inc filed Critical MEDICAL INNOVATIONS Inc
Priority to JP48044268A priority patent/JPS586502B2/en
Application granted granted Critical
Publication of US3835845A publication Critical patent/US3835845A/en
Assigned to INTERMEDICS CARDIASSIST, INC. reassignment INTERMEDICS CARDIASSIST, INC. ASSIGNMENT OF ASSIGNORS INTEREST. Assignors: CARDIASSIST CORPORATION
Assigned to FIRST FREEPORT NATIONAL BANK, CITIBANK, N.A., AS AGENT, BRAZOSPORT BANK OF TEXAS, BANK OF AMERICA NATIONAL TRUST AND SAVINGS ASSOCIATION,, TRUST COMPANY BANK, FIRST NATIONAL BANK OF CHICAGO, THE, CHASE MANHATTAN BANK, N.A., THE reassignment FIRST FREEPORT NATIONAL BANK SECURITY INTEREST (SEE DOCUMENT FOR DETAILS). SUBECT TO CONDITIONS INVOLVING SAID PATENTS IN SCHEDULE II (SEE DOCUMENT FOR DETAILS) Assignors: AMERICAN PACEMAKER CORPORATION, CALCITEK, INC., INTERMEDICS CARDIASSIST, INC., INTERMEDICS INTRAOCULAR, INC., INTERMEDICS, INC., INTERVASCULAR, INC., MASTER IMAGES, INC., NEUROMEDICS, INC., SURGITRONICS CORPORATION
Assigned to CHASE COMMERCIAL CORPORATION reassignment CHASE COMMERCIAL CORPORATION SECURITY INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: AMERICAN PACEMAKER CORPORATION, A CORP. OF MA., CALCITEK, INC., A CORP. OF TEXAS, CARBOMEDICS, INC., INTERMEDICS CARDIASSIST, INC., A CORP OF TX., INTERMEDICS INTRAOCULAR, INC., A CORP. OF TEXAS, INTERMEDICS, INC., A CORP. OF TEXAS, NEUROMEDICS INC., A CORP. OF TEXAS, SURGITRONICS CORPORATION, A CORP. OF TEXAS
Assigned to CITICORP MILTILEASE (SEF), INC. reassignment CITICORP MILTILEASE (SEF), INC. SECURITY INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: AMERICAN PACEMAKER CORPORATON, A CORP. OF MA., CALCITEK, INC., A CORP. OF TEXAS, CARBOMEDICS, INC., A CORP. OF TEXAS, INTERMEDICS CARDIASSIST, INC., INTERMEDICS INTRAOCULAR, INC., A CORP. OF TEXAS, INTERMEDICS, INC., NEUROMEDICS, INC., SURGITRONICS CORPORATION, A CORP. OF TEXAS
Assigned to CITIBANK, N.A. reassignment CITIBANK, N.A. SECURITY INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: AMERICAN PACEMAKER CORPORATION A MA CORP., CALCITEK, INC., A TX CORP., CARBOMEDICS, INC., A TX CORP., INTERMEDICS CARDIASSIST, INC., A TX CORP., INTERMEDICS INTRAOCULAR, INC., A TX CORP., INTERMEDICS, INC., A TX CORP, NEUROMEDICS, INC., A TX CORP, SURGITRONICS CORPORATION A TX CORP.
Assigned to B.A. LEASING CORPORATION reassignment B.A. LEASING CORPORATION SECURITY INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: AMERICAN PACEMAKER CORPORATION, A CORP. OF MA., CALCITEK, INC., CARBOMEDICS, INC.,, INTERMEDICS CARDIASSIST, INC., INTERMEDICS INTRAOCULAR, INC., A CORP. OF TEXAS, INTERMEDICS, INC., A CORP. OF TEXAS, NEUROMEDICS, INC., A CORP. OF TEXAS, SURGITRONICS CORPORATION, A CORP. OF TEXAS
Assigned to INTERMEDICS, INC., INTERMEDICS CARDIASSIST, INC., INTERMEDICS INTRAOCULAR, INC., SURGITRONICS CORPORATION, CARBOMEDICS, INC., NEUROMEDICS, INC., CALCITEK, INC., TEXAS CORPORATION AND AMERICAN PACEMAKER CORPORATION, A CORP OF MASS. reassignment INTERMEDICS, INC., INTERMEDICS CARDIASSIST, INC., INTERMEDICS INTRAOCULAR, INC., SURGITRONICS CORPORATION, CARBOMEDICS, INC., NEUROMEDICS, INC., CALCITEK, INC., TEXAS CORPORATION AND AMERICAN PACEMAKER CORPORATION, A CORP OF MASS. SECURED PARTY HEREBY RELEASE THE SECURITY INTEREST IN AGREEMENT RECORDED AUGUST 5, 1985. REEL 4434 FRAMES 728-782 Assignors: CITIBANK, N.A.
Assigned to INTERMEDICS, INC. reassignment INTERMEDICS, INC. RELEASED BY SECURED PARTY (SEE DOCUMENT FOR DETAILS). Assignors: CITICORP MULTILEASE (SEF), INC.
Assigned to INTERMEDICS, INC., INTERMEDICS CARDIASSIST, INC., INTERMEDICS INTRAOCULAR, INC., SURGITRONICS CORPORATION, CARBOMEDICS, INC., NEUROMEDICS, INC., CALCITEK, INC., INTERVASCULAR, INC., AND MASTER IMAGES, INC., TEXAS CORPORATIONS, AND AMERICANPACEMAKER CORPORATION, A CORP. OF MA. reassignment INTERMEDICS, INC., INTERMEDICS CARDIASSIST, INC., INTERMEDICS INTRAOCULAR, INC., SURGITRONICS CORPORATION, CARBOMEDICS, INC., NEUROMEDICS, INC., CALCITEK, INC., INTERVASCULAR, INC., AND MASTER IMAGES, INC., TEXAS CORPORATIONS, AND AMERICANPACEMAKER CORPORATION, A CORP. OF MA. SAID PARTIES RECITES OBLIGATIONS RECITED IN SECURITY AGREEMENT RECORDED SEPTEMBER 17, 1984 REEL 4303 FRAMES 077-127 HAVE BEEN PAID IN FULL ALL SEE RECORD FOR DETIALS Assignors: CITIBANK, N.A., INDIVIDUALLY AND AS AGENT FOR BANK OF AMERICA NATIONAL TRUST AND SAVINGS ASSOCIATION, THE CHASE MANHATTAN BANK, N.A., THE FIRST NATIONAL BANK OF CHICAGO, TRUST COMPANY BANK, FIRST FREEPORT NATIONAL BANK OF BRAZOSPORT BANK OF TEXAS
Assigned to MAY PARTNERSHIP, THE reassignment MAY PARTNERSHIP, THE SECURITY INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: AMERICAN PACEMAKER CORPORATION A MA CORP., CALCITEK, INC., CARBOMEDICS, INC., INTERMEDICS CARDIASSIST, INC., INTERMEDICS INFUSAID, INC. TX CORPS., INTERMEDICS, INC.,, SURGITRONICS CORPORATION
Assigned to CARBOMEDICS, INC., A TEXAS CORP., INTERMEDICS CARDIASSIST, INC., A TEXAS CORP., INTERMEDICS, INC., A TEXAS CORP., CALCITEK, INC., A TEXAS CORP., NEUROMEDICS, INC., A TEXAS CORP., AMERICAN PACEMAKER CORPORATION, A MASSACHUSETTS CORP., SURGITRONICS CORPORATION, A TEXAS CORP., INTERMEDICS INTRAOCULAR, INC., A TEXAS CORP. reassignment CARBOMEDICS, INC., A TEXAS CORP. RELEASED BY SECURED PARTY (SEE DOCUMENT FOR DETAILS). Assignors: B. A. LEASING CORPORATION
Assigned to INTERMEDICS CARDIASSIST, INC., INTERMEDICS, INC., SURGITRONICS CORPORATION, INTERMEDICS INTRAOCULAR, INC., CARBO-MEDICS, INC. reassignment INTERMEDICS CARDIASSIST, INC. RELEASED BY SECURED PARTY (SEE DOCUMENT FOR DETAILS). Assignors: CHASE COMMERCIAL CORPORATION
Assigned to INTERMEDICS, INC. reassignment INTERMEDICS, INC. RELEASED BY SECURED PARTY (SEE DOCUMENT FOR DETAILS). RECORDED AT REEL 4581, FRAMES 501-531 (SEE RECORD FOR DETAILS) Assignors: MAY PARTNERSHIP, THE, BY: ROLLINS HOLDING COMPANY, INC.
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61HPHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY
    • A61H9/00Pneumatic or hydraulic massage
    • A61H9/005Pneumatic massage
    • A61H9/0078Pneumatic massage with intermittent or alternately inflated bladders or cuffs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/02Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
    • A61B5/026Measuring blood flow
    • A61B5/0285Measuring or recording phase velocity of blood waves
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61HPHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY
    • A61H2230/00Measuring physical parameters of the user
    • A61H2230/04Heartbeat characteristics, e.g. E.G.C., blood pressure modulation

Definitions

  • the control means consists of a marker 128/2 O6 i 5 means, such as a pip on an oscilloscope, which is adjustable by variable-delay circuitry throughout a range [56] References Cited equal to the time difference between the sensing of a selected cardiac event at an earliest-reacting monitor- UNITED STATES PATENTS ing site and the sensing of a selected cardiac event at Becker R a later reacting monitoring site 3,734,087 5/1973 Sauer et al 128/64 8 Claims, 4 Drawing Figures TO 9O l WATER EMPTY /62 64 68 FROM"2 EMPTY PUMP PRESSURE SENSOR CONTROL DELAY I j DURATION CONTROL CONTROL 89 84 I96 w I PRESSURE V Q QQE DELAY DURATION 2g???
  • This invention relates to a novel apparatus for assisting blood flow in the circulatory system by synchronizing the pulsing of an external-assist means with the heartbeat and particularly relates to a novel synchronization-control system for use with the aforesaid appara- H15.
  • synchronous external pressure assist processes are distinguishable and advantageous over pre-existing counter-pulsation processes because the latter kind of procedure involves the cannulation of a major artery, use of an extra-corporeal blood handling device, the use of stringently sterile techniques and the necessity of administering anticoagulants to the patient.
  • the blood trauma or hemolysis produced by extra-corporeal pumping devices limits permissible duration of the assist procedure and compromises the condition of the patient.
  • these trauma-requiring procedures are not only time consuming, they can present a very significant hazard to many patients, and they increase the risk factor in treating all patients.
  • the external counterpulsation method is the only controlled method of assist which requires no surgical intervention or sterile procedures, no use of anticoagulants or anesthesia, and produces no significant trauma. These factors are most important because they usually allow a much earlier use of the apparatus on a patient in, say, a state of circulatory shock than could be justified if another type of assist apparatus had to be used.
  • the selective application of positive and negative pressures to the portion of the vascular bed in the legs serves to control directly the volume of blood within that portion of the vascular bed and, hence, the pressures within the arterial system, particularly the pressures of the aorta. It is these controlled changes in aortic pressure that lead directly to a reduction in cardiac work, to increased perfusion of the systemic circulation, and to preferential perfusion of the myocardium.
  • the control system of the aforesaid improved apparatus comprises a built-in 80-second delay factor adapting it for use on the pre-selected wrist sensing site.
  • the beginning of diastole is indicated in the arterial wave by the so-called dicrotic notch in good approximation by the end of the so-called T-wave which is known to be positive indication of the relaxation of the left ventricle and the end of systole.
  • the leg pressurization signal was used to intensify the ECG and arterial trace on the oscilloscope after this pressurization signal has been delayed for 80 and 170 ms respectively.
  • the duration of intensification is the duration of each positive pressurization cycle of the leg.
  • Another object of the invention is to provide an external circulatory assist device having a synchronizationcontrol means of greater versatility.
  • Another object of the invention is to provide an apparatus easily synchronized by personnel of moderate skill and training.
  • a further object of the invention is to provide an improved control means and method which allows the operator of the apparatus to accurately synchronize the apparatus without (1) the necessity of precise prediction of the time delay between the heart action and its effect on the arterial wave sensing site and (2) without predicting the sensing site to be selected.
  • the above objects have been substantially achieved by controlling the synchronization of the external circulatory assist apparatus with a control means whereby the optimum time period between a certain cardiac event (typically the R wave of an ECG curve) and the triggering of the circulatory assist pressure is precisely achieved by a visual and movable indicator means which can be moved during the setting of a time variable, throughout a time range which allows compensation for the time differences between the cardiac event and its manifestation at any arterial-wave sensing site which may be selected at the time of treatment.
  • a control means whereby the optimum time period between a certain cardiac event (typically the R wave of an ECG curve) and the triggering of the circulatory assist pressure is precisely achieved by a visual and movable indicator means which can be moved during the setting of a time variable, throughout a time range which allows compensation for the time differences between the cardiac event and its manifestation at any arterial-wave sensing site which may be selected at the time of treatment.
  • the visual marker is advantageously electronic and moved along a channel of an oscilloscope as a trace intensification of a finger plethysmograph, or some like manifestation of a cardiac event, until the marker is positioned at an easily-recognized point on the curve (e.g., at a point indicative of the start of systole).
  • FIGS. 1 and 2 taken together, are a schematic diagram of an external circulatory assist apparatus, including the control means which forms the particular improvement of this invention.
  • FIG. 3 is a graph illustrating, in real time, the relationship of an electrocardiographic curve and external circulatory assist pressurization.
  • FIG. 4 is a graph showing curves similar to those which would appear on a two-channel oscilloscope, displaying (I) an electrocardiographic curve and (2) any of several alternative curves manifesting the heartbeat as it is manifested by pressure at the central aorta, a radial artery or a finger.
  • a transducer-type pressure sensor 34 including a sensing bladder 35 is utilized to sense hydraulic pressure in bladder 22. If the pressure so sensed is less than 20 millimeters of mercury (mm of Hg), then a pressure-level amplifier 46 will provide an output to the and-type gate 48. If during this low-pressure signal situation, the operator closes a water fill switch 50, he will cause the and gate 48 to transmit a signal which will activate a fill pump 52 through pump control circuit 54 and simultaneously cause a multiposition, solenoid valve 56 to shift to its fill position, i.e., the position allowing water to flow from conduit 58 to conduit 60.
  • a fill pump 52 through pump control circuit 54 and simultaneously cause a multiposition, solenoid valve 56 to shift to its fill position, i.e., the position allowing water to flow from conduit 58 to conduit 60.
  • Water is emptied from bladder 22 by using an analogous system whereby pressure is sensed by sensor 62.
  • a signal is sent to and-gate" 64. If empty switch 66 is closed, the gate 64 will allow a signal command to actuate pump control 68 and empty pump 69 and cause solenoid valve 56 to shift to its empty position, i.e., the position allowing water to flow from conduit 60 to conduit 70 and thence back to water reservoir 72 through 74.
  • the pump 69 will empty until a pressure of less than the illustrative minus 15 mm Hg is sensed. At that time the and-gate" 64 will no longer sense the required signal from sensor 62, and the pump 69 will be turned off and valve 56 will return to its off position.
  • the pressure within bladder 34 is maintained at its desired level by adding or removing water from the bladder system as follows:
  • a displacement sensing type transducer 76 is" mounted on hydraulically-actuated rod .78. Transducer 76 is adapted to provide an electrical signal output pro-.
  • a normalized value of the position of rod 78 is provided by feeding the signal from transducer 76 intoa by numeral 415 in FIGS. 3 and 4.)
  • a manually controlled delay 86 is to convert the original signal from first trigger generator 84 to a second time-delayed signal corresponding in real time with the beginning of cardiac diastole. This second signal enters a duration signal generator 88.
  • Generator 88 is so selected that the signal therefrom continues for the length of time that leg pressurization (as caused by pressure in bladder 34) is desired.
  • This signal from generator 88 is fed to level comparator 82 through a level strobe signal generator 89.
  • the signal from generator 88 is also fed to a waveform generator 90 which produces a wave whose amplitude and shape is analogous to that desired for the leg pressurization sequence.
  • a typical such wave will be trapazoidal-like in shape with a rise of 60 ms, a plateau of 250 ms, and a fall of 60 ms.
  • This wave from generator 90 is fed to a wave form comparator 92 wherein it is continually compared to a signal derived from the actual bladder pressure wave as experienced by sensor 34.
  • the output of comparator 92 is a so-called error signal, i.e., a signal which is indicative of the quality and strength of the difference between the desired wave signal from generator 90 and the actual wave signal from sensor 34.
  • a typical generated wave will normally have a total positive pressure period of from about 250 to about 300 milliseconds.
  • the rise and fall in pressure will take about 60 ms each and rise will start about 80 ms before diastole.
  • the error signal is used to control servo valve 94 through a servo-amplifier 93 and thereby controls the supply of fluid to, and consequently the movement of, hydraulic cylinder 78.
  • level comparator 82 receives two signals: one, a periodic signal from a duration signal generator 88, via strobe signal generator 89 and the other from displacement level sensor 80.
  • lever comparator 82 compares these two signals, one indicative of the actual position of hydraulic cylinder 78 at a given time. It is the periodic, or strobe signal from duration signal generator 88, as modified by a level strobe signal generator 89, which determines when this comparison is to be made. The comparison is most usefully made at the time platen 30 is in the upper-most portion of its stroke and pressing firmly against bladder 22.
  • level comparator 82 senses that the uppermost position of platen 30 is too high, output signal is provided to a one shot (monostable multivibrator) 96.
  • This one shot 96 will then turn on fill pump 52 and also position solenoid valve 56 for a 0.5-second fill period.
  • the 0.5-second fill periods will continue during each cardiac period, (i.e., each heartbeat) until the water volume in bladder 22 is sufficient so that the uppermost position of platen 30 is within an acceptable displacement range at the top of its stroke.
  • the level comparator 82 receives a signal that the uppermost position of platen 30 is too low in its stroke, the uppermost position of empty pump is turned on for one-half second on each cardiac cycle by activation of the one shot device 98 and the empty pump 69. Water is then pumped out of the bladder until the platen achieves a desired rise during its stroke.
  • a signal from any given arterial pressure-sensing device 99 is fed into a dual trace oscilloscope 101 along with a signal from ECG device 102. These signals appear only as width intensifications 103 of ECG trace 104 and the arterial trace 106.
  • FIG. 3 shows the relative real timing of the cardiac cycle as represented by electrocardiogram 402, radial arterial pressure waveform 407, and the curve 404, representing the leg pressure rise 405 exerted by the external circulatory assist device on legs of a patient.
  • the electrocardiograph is characterized by R wave 415, sometimes called a QRS complex, and a T wave 420 see FIG. 4.
  • the beginning of systole is manifested at 399 or about 40 ms after the R wave peak 415.
  • a radial arterial sensing of this heart action will provide a waveform representative of the heart cycle; however, the precise time at which the arterial waveform is sensed, as shown in FIG. 4, will be out of phase with the ECG signal itself by a time dependent on the particular site at which the arterial waveform is sensed.
  • a modified waveform, and not the arterial waveform itself will be sensed at the radial arterial sites.
  • These modified arterial waveforms are characterized by a so-called dicrotic notch 409 which is a manifestation of the beginning of diastole in the cardiac cycle.
  • the external assist pressurization for example at the legs, was to occur at a time (D,) after the triggering signal; milliseconds later the pressure wave reached the heart and after more milliseconds it was sensed at the wrist, the pre-selected sensing site.
  • D time
  • the external pressure wave became effective at the heart at the start of diastole as desired.
  • This time corresponds, with reference to an arterial waveform, to the appearance of dicrotic notch 409 on the arterial waveform at the wrist and the apparatus was designed to initiate the pressure pulse at the legs at a time equal to seconds before the manifestation of diastole at the wrist.
  • a signal from an arterial pressure-sensing device 99 was fed into a dual trace oscilloscope 101 along with a signal from ECG device 102.
  • the duration of an intensification of these signals was the duration of a pressure command signal as receiyed from druation signal gen: erator 88 and appeared as intensifications of ECG trace 104 and arterial trace 106.
  • D i.e., variable delay 86 was used to bring the intensification signal into register with the diastolic period as viewed on either the ECG or arterial traces, thereby simultaneously phasing the pressurization wave to the cardiac cycle.
  • the operator of the apparatus also has variable control means for changing the characteristics of the duration signal generator 88 to provide the intensified signal duration which is required for a particular patient. On the oscilloscope 100, this duration showed up as intensifications 103 of the oscilloscope traces.
  • This prior control system depended for optimum operation on the pre-selection of a particular arterialsensing site, such as the wrist, which would typically be about 90 milliseconds out of phase with the ECG cycle.
  • a signal from an ECG device 102 is fed through a trigger generator 84, delay 86, and duration signal generator 88, into an 80 ms delay device 110 as before.
  • the output from device 110 a pulse equal in duration to D is delayed from the R wave by a time D (imparted by delay 86) plus 80 milliseconds. This pulse is used to provide the ECG (Channel 1) intensification.
  • variable delay device 112 from which-a signal is obtained which is delayed from the R wave by a time equalling D plus 80 milliseconds plus D wherein D is the variable delay imparted by adjustable delay device 112.
  • the trigger signal from trigger generator 84 is being fed to a 40-millisecond delay device 114, and thence to a variable delay device 116.
  • the output from device 116 is fed to a marker generator 118, which generates a marker pulse delayed from the R wave by D plus 40 milliseconds wherein D is the variable delay imparted by adjustable delay device 116.
  • the signals from marker generator 118 and delay device 112 are fed into pulse mixer 120 and the resulting signal is fed to the channel 2 trace of the oscilloscope, i.e., that channel showing the arterial waveform.
  • a marker pip from generator 118 is moved along arterial trace 106 to a position which is at the start of systole, e.g., as shown at 414. This position is characterized by the start of a fast rise 403 in the arterial trace.
  • the marker pip can be moved by use of marker position control 122 throughout a range equivalent to the D variable time delay simultaneously achievable with delay devices 112 and 116. As the marker pip is so moved, the intensified trace provided by duration generator 86 and representative of the external assist pressure stroke follows the marker pip but is delayed by an amount D less 40 milliseconds from the marker pip.
  • variable delay device 86 i.e., D will be set by adjusting delay control 124 to bring the intensification signal into register with the dicrotic notch, thereby adjusting the time between notch and the intensification signal to a time represented in FIG. 4 by D
  • duration generator 88 is set by adjusting duration control 126 to give the proper pulse length, i.e., as shown by numerals 410, 411, 412 and 413 for ECG,
  • an external circulatory assist apparatus comprising means to pressurize a portion of a patients body, means to synchronize actuation of said pressurization means on a portion of the body with the heart cycle of a patient being treated, means for creating an arterial waveforms signal representative of said heart cycle, and display means for monitoring a said waveform signal exhibiting a dicrotic notch portion representative of said heart cycle in the form of visible traces on said display means the improvement wherein said synchronizing means includes:
  • C. means to, concurrently with the adjustment of said first marker pip, move a second intensified pip along said waveform at a constant distance from said first marker
  • said means to provide said second said intensified marker pip comprises means to form an ECG-derived signal, a signal generator, means for triggering said signal generator by said ECG-derived signal, a variable delay means, a marker pip generator, and a pulse mixer for integrating said second marker pip signal with a signal representative of a pressure wave exerted by said external assist apparatus on said patient.
  • variable delay means provides a delay variable over a time difference at least equal to the time elapsing from diastole in a patients heart cycle to the time such diastole is registered in said patients digital extremities.
  • position adjusting means provide means to adjust said marker pip over a portion of the waveform equivalent in length to time elapsing from diastole in a patients heart cycle to the time such diastole is registered in said patients digital extremities.
  • apparatus for applying external pressure assist action to the limbs of a patient in cyclic synchronization with the heartbeat of said patient wherein said assist is achieved with means for transmitting pressure to said limbs through a fluid-filled bladder pressurizing means surrounding said limbs, means for creating an arterial waveform signal representative of said heartbeat and display means for monitoring a said waveform signal representative of said hearbeat in the form of visible traces on said display means, wherein the apparatus also includes a visual cycle-phasing monitor comprising:
  • A. means to provide a first marker pip on display apparatus displaying a marker trace representative of a radial arterial waveform derived from a patient
  • D. means to move, concurrently with said adjusting, an intensified trace along said waveform at a constant distance from said first marker
  • E. means to bring said intensified trace into register with the dicrotic notch of said waveform, thereby adjusting the synchronization for activating said pressure command signal.
  • apparatus for applying external pressure assist action to the limbs of a patient in cyclic synchronization with the heartbeat of said patient
  • said apparatus comprises means for producing a pressure command signal, means for transmitting pressure through a hydraulic cylinder to said limbs through a fluid-filled bladder pressurizing means surrounding said limbs in response to means for activating said pressure command signal, and means for creating an arterial waveform signal representative of said heartbeat and display means for monitoring a said waveform signal representative of said heartbeat in the form of visible traces on said display means
  • the apparatus includes A. an ideal pressure waveform generator means,
  • said display means forming means for continually comparing said ideal and actual waveforms
  • variable valve means responsible to a signal from said comparing means, to modify fluid flow to said hydraulic cylinder and thereby to transmit pressure to said limbs through said fluid-filled bladder more nearly achieve said ideal-pressure waveform at said limbs the improvement wherein said apparatus comprises:
  • A. means to provide a first marker pip on display apparatus displaying a marker trace representative of said arterial waveform derived from a patient
  • D. means to move, concurrently with said adjusting, an intensified trace along said waveform at a constant distance from said first marker
  • E. means to bring said intensified trace into register with the dicrotic notch of said waveform, thereby adjusting the synchronization for activating said pressure command signal.
  • Apparatus as defined in claim 6 comprising: A. a multi-channel oscillosopce adapted to display 1. an ECG trace, and

Abstract

Improved internal circulatory assist apparatus comprising control means whereby the optimum synchronization of the assist apparatus with the beat of the heart can be effectively achieved while using any of a plurality of parts of the body as monitor sites for obtaining an arterial signal representative of the patient''s heartbeat. The control means consists of a marker means, such as a pip on an oscilloscope, which is adjustable by variable-delay circuitry throughout a range equal to the time difference between the sensing of a selected cardiac event at an earliest-reacting monitoring site and the sensing of a selected cardiac event at a later-reacting monitoring site.

Description

United States Patent Maher CARDIAC SYNCHRONIZATION SYSTEM AND METHOD IIII 3,835,845
[ Sept. 17, 1974 [75] Inventor: Charles E. Maher, Brockton, Mass. MCKenna; Andrew Kehoe [73] Assignee: xiii-cal Innovations, Inc., Waltham, ABSTRACT [22] Filed: Oct 24 1972 Improved internal circulatory assist apparatus comprising control means whereby the optimum synchro- [21] Appl. No.: 300,290 nization of the assist apparatus with the beat of the heart can be effectively achieved while using any of a [52] Us. CL 128/64 28/2 05 R 128/2 06 R plurality of parts of the body as monitor sites for ob- [51 1 Int Cl A6lh' 9/00 taining an arterial signal representative of the patients [58] Field P 205 R heartbeat. The control means consists of a marker 128/2 O6 i 5 means, such as a pip on an oscilloscope, which is adjustable by variable-delay circuitry throughout a range [56] References Cited equal to the time difference between the sensing of a selected cardiac event at an earliest-reacting monitor- UNITED STATES PATENTS ing site and the sensing of a selected cardiac event at Becker R a later reacting monitoring site 3,734,087 5/1973 Sauer et al 128/64 8 Claims, 4 Drawing Figures TO 9O l WATER EMPTY /62 64 68 FROM"2 EMPTY PUMP PRESSURE SENSOR CONTROL DELAY I j DURATION CONTROL CONTROL 89 84 I96 w I PRESSURE V Q QQE DELAY DURATION 2g??? GENERATOR 0 E T GENERATOR 80 ms. l0 DELAY "4 MARKER POSITION i CONTROL 0| 40 ms. DUAL TRACE OSCILLOSCOPE DELAY I EKG TRACE I16 99 I03 203 2 R & w VARIABLE VARIABLE ARTERIAL -EH a PRESSURE INTENSITY INTE \ISITY 2 2 IN CONTROL CONTROL TRACE l TRACE 2 {H8 D +8OmS. ECG TRACE MARKER GENERATOR 56" 1 {J PULSE I20 MIXER M m" PAIENTEB 71974 3.835.845
SHEET 1 [IF 3 II II DESIRED PRESSURE FROM 88 WAVEFORM 22 /9O 34 35 WAVEFORM m fbw GENERATOR WAVEFORM 92 COMPARATOR HYDRAULIC 7 CYLINDER ERROR SIGNAL 8O SERVO a2 STROBE SI AL v AMPLIFIER {FROM 89 LEvEL L SENSOR SERvO id i vA LvE LEVEL COMPARATOR 9 98 ,,ONE SHOT I f OIL RESERVOIR ACCuMuLATOR I v S/ ONE SHOT I vALvE RESERVOIR L FILL FMPTY PUMP PUMP I OFF. H20 69 [PUMP CONTROL VALVE CIRCUIT FROM "68 E H2O L60 FIG.|
F I G. 2
P u SEP I 71874 SHEET 2 [IF 3 E .E. .E
1 WATER EMPTY /-62 64 68 FROM"2 E EEEEEUEE ggg gg SENSOR DELAY DURATION cONTROL CONTROL 1 I I LEvEL yggy; J1 DELAY L %%%%+fi GENERATOR D| GEN%:ATOR GENERATOR 80 ms. /HO DELAY I22 MARKER POSITION Q CONTROL 1 I lo] 40 ms. DuAL. TRACE OSOILLOSOOPE/ r DELAY EKG TRACE Q6 99 VARIABLE VAFEIABLE ARTERIAL PRESSURE INTENSITY INTENsITY 2 2 IN OONTROL CONTROL TRAcE I TRAcE 2 Ila D +80 ms. g ECG TRACE MARKER GENERATOR TO "56" r PULSE I2O NIIxER PAIEIIIIINIIIT I 3.835.845
SHEEI 3 OF 3 -TRIGGERING SIGNAIL I I l I 409 LLI I I 3; I00 I I I 80 I I .l
60 I I 3 40 I I I DELAY TIME To LEG 5 20 I I KIPRESSURIZATION E O I DI .I I I 405\ -D4 YI I I 4o4\ I I I I [NF/O ms. I FTIME HEART wAvE I l 415 A ms SENSED AT wRIsT TIME FOR wAvE TO I REACH HEART I I HMISTART OF DIASTOLE (EKG) I I 403 START OF DIASTOLE I I- (WRIST) ECG I I I; I I I I I I II I I I 0 80 I60 240 320 400 480 560 e40 720 800 880 F I G 3 TIME (MILLISECONDS) I I I I I DIASTOLE (FINGER) -4I5 I I I I l I I CHANNEL I ECG ALTERNATE I "211%;
cENTRAL AoRTA I 42 O ALTERNATE 2 1212551275255 CHANNEL 2 ALTERNATE 3 ARTERIAL CARDIAC SYNCHRONIZATION SYSTEM AND METHOD BACKGROUND OF THE INVENTION 1. Field of the Invention This invention relates to a novel apparatus for assisting blood flow in the circulatory system by synchronizing the pulsing of an external-assist means with the heartbeat and particularly relates to a novel synchronization-control system for use with the aforesaid appara- H15.
2. Background of the Invention Methods for atraumatically assisting blood circulation of patients have been described in the art. In U.S. Pat. No. 3,303,841 to Dennis, a process is described whereby an external compressing of the lower part of the body expresses a volume of blood larger than the volume of blood pumped in a single stroke of the heart. The blood so expressed is forced back into the aorta and greater arterial vessels and thereby allows a reduction in ventricular workload while maintaining a satisfactory perfusion of blood during ventricular diastole. This general type of process has been elaborated upon in an article entitled Synchronous Assisted Circulation by Birtwell et al., appearing in The Canadian Medical Association Journal (Vol. 95, pages 652-664) on Sept. 24, 1966. In general, synchronous external pressure assist processes are distinguishable and advantageous over pre-existing counter-pulsation processes because the latter kind of procedure involves the cannulation of a major artery, use of an extra-corporeal blood handling device, the use of stringently sterile techniques and the necessity of administering anticoagulants to the patient. Moreover, the blood trauma or hemolysis produced by extra-corporeal pumping devices limits permissible duration of the assist procedure and compromises the condition of the patient. Finally, these trauma-requiring procedures are not only time consuming, they can present a very significant hazard to many patients, and they increase the risk factor in treating all patients.
In U.S. Pat. No. 3,654,919 to Birtwell, an improved external assist apparatus was described wherein the effective pressure on circulatory passages of the legs could be cycled to valves at or below ambient pressure. This apparatus is a major advance in the art and has been extensively used as a vehicle for evaluating the therapeutic potential of externally assisted circulation. Some results of this work are reported in a paper entitled The Hemodynamic Evaluation of External Counterpulsation in Man by T. J. Ryan et al., and presented at the American Heart Association Scientific Sessions held in Atlatntic City, N.J., during November 1970.
At the present time the external counterpulsation method is the only controlled method of assist which requires no surgical intervention or sterile procedures, no use of anticoagulants or anesthesia, and produces no significant trauma. These factors are most important because they usually allow a much earlier use of the apparatus on a patient in, say, a state of circulatory shock than could be justified if another type of assist apparatus had to be used.
The selective application of positive and negative pressures to the portion of the vascular bed in the legs serves to control directly the volume of blood within that portion of the vascular bed and, hence, the pressures within the arterial system, particularly the pressures of the aorta. It is these controlled changes in aortic pressure that lead directly to a reduction in cardiac work, to increased perfusion of the systemic circulation, and to preferential perfusion of the myocardium.
An improved system for providing the desired synchronization of the heartbeat and the external assist apparatus has been developed more recently. That system utilized a feedback signal from the external pressurization of the legs, directly compared this signal to a control signal representative of the desired waveform for treatment of the patient and used an error signal derived from the difference between the aforesaid feedback signal and the control signal to achieve an adjustment of the pressurization to the desired waveform. This pressurization, if not properly timed with respect to the heartbeat, could cause a deleterious, physiological effect on the patient. Therefore, a simple, accurate, automatic phasing means was disclosed, whereby an arterial waveform from the patient is displayed on a multi-channel oscilloscope (or other suitable display device) in conjunction with an elecrocardiographic waveform. The arterial pressure waveform would be obtained at a pre-selected site, for example, at the wrist, and the electrocardiographic waveform is obtained by placement of sensors directly on the torso of the patient proximate the heart.
It takes about milliseconds (ms) for a pressure wave, introduced in the femoral arteries with the apparatus of the invention, to reach the root of the aorta. The subsequent transmission from the root of the aorta to the wrist, where the arterial waveform was typically obtained, takes another ms. It is important that the artificially-induced positive pressure waves be produced in the legs sufficiently before diastole (80 ms) and that the pressure wave reaches the root of the aorta at the beginning of diastole. Therefore the control system of the aforesaid improved apparatus comprises a built-in 80-second delay factor adapting it for use on the pre-selected wrist sensing site.
The start of the augmented diastolic waveform, as seen at the wrist, which results from use of the applicants apparatus, therefore will take place about ms after the pressure is applied to the legs of the patient. In such a situation, it is desirable to have the induced pressure wave initiated by a command signal timed to start 170 ms before the arterial wave, as seen at the wrist indicates the beginning of diastole and 80 ms before the ECG signal indicates the beginning of diastole. The beginning of diastole is indicated in the arterial wave by the so-called dicrotic notch in good approximation by the end of the so-called T-wave which is known to be positive indication of the relaxation of the left ventricle and the end of systole.
In the signal phasing system, the leg pressurization signal was used to intensify the ECG and arterial trace on the oscilloscope after this pressurization signal has been delayed for 80 and 170 ms respectively. The duration of intensification is the duration of each positive pressurization cycle of the leg. With the system, an operator could adjust the delay time until the intensified signal on the ECG or arterial wave fonn is located at the beginning of a diastole. At that point, leg pressurization can be triggered in correct synchronization with the cardiac cycle.
Although the above-described system is generally useful and has been used successfully in some situations, it had the drawback of depending on a predicted constant delay between the aortic event and the selected sensing site. It has now been discovered to be desirable to provide a more versatile means of synchronizing the heartbeat and the apparatus.
SUMMARY OF THE INVENTION Therefore, it is an object of the invention to provide an improved external circulatory assist apparatus.
Another object of the invention is to provide an external circulatory assist device having a synchronizationcontrol means of greater versatility.
Another object of the invention is to provide an apparatus easily synchronized by personnel of moderate skill and training.
A further object of the invention is to provide an improved control means and method which allows the operator of the apparatus to accurately synchronize the apparatus without (1) the necessity of precise prediction of the time delay between the heart action and its effect on the arterial wave sensing site and (2) without predicting the sensing site to be selected.
Other objects of the invention will be obvious to those skilled in the art on their reading this application.
The above objects have been substantially achieved by controlling the synchronization of the external circulatory assist apparatus with a control means whereby the optimum time period between a certain cardiac event (typically the R wave of an ECG curve) and the triggering of the circulatory assist pressure is precisely achieved by a visual and movable indicator means which can be moved during the setting of a time variable, throughout a time range which allows compensation for the time differences between the cardiac event and its manifestation at any arterial-wave sensing site which may be selected at the time of treatment.
The visual marker is advantageously electronic and moved along a channel of an oscilloscope as a trace intensification of a finger plethysmograph, or some like manifestation of a cardiac event, until the marker is positioned at an easily-recognized point on the curve (e.g., at a point indicative of the start of systole).
ILLUSTRATIVE EXAMPLE OF THE INVENTION In this application and accompanying drawings there is shown and described a preferred embodiment of the invention and suggested various alternatives and modifications thereof, but it is to be understood that these are not intended to be exhaustive and that other changes and modifications can be made within the scope of the invention. These suggestions are selected and included for purposes of illustration in order that others skilled in the art will more fully understand the invention and the principles thereof and will be able to modify it in a variety of forms, each as may be best suited in the condition of a particular case.
IN THE DRAWINGS FIGS. 1 and 2, taken together, are a schematic diagram of an external circulatory assist apparatus, including the control means which forms the particular improvement of this invention.
FIG. 3 is a graph illustrating, in real time, the relationship of an electrocardiographic curve and external circulatory assist pressurization.
FIG. 4 is a graph showing curves similar to those which would appear on a two-channel oscilloscope, displaying (I) an electrocardiographic curve and (2) any of several alternative curves manifesting the heartbeat as it is manifested by pressure at the central aorta, a radial artery or a finger.
Referring now to FIGS. 1 and 2, it is seen that a transducer-type pressure sensor 34 including a sensing bladder 35 is utilized to sense hydraulic pressure in bladder 22. If the pressure so sensed is less than 20 millimeters of mercury (mm of Hg), then a pressure-level amplifier 46 will provide an output to the and-type gate 48. If during this low-pressure signal situation, the operator closes a water fill switch 50, he will cause the and gate 48 to transmit a signal which will activate a fill pump 52 through pump control circuit 54 and simultaneously cause a multiposition, solenoid valve 56 to shift to its fill position, i.e., the position allowing water to flow from conduit 58 to conduit 60. Thereupon water will flow into the bladder 22 until a pressure of 20 mm Hg is sensed by pressure sensor 34. The signal from amplifier 46 will then drop consequently closing andgate" 48. Thereupon, fill pump 52 is deactivated and solenoid valve 56 is shifted to its off position.
Water is emptied from bladder 22 by using an analogous system whereby pressure is sensed by sensor 62. In a typical mode of operation, if the pressure sensed is above a minus 15 mm Hg value, a signal is sent to and-gate" 64. If empty switch 66 is closed, the gate 64 will allow a signal command to actuate pump control 68 and empty pump 69 and cause solenoid valve 56 to shift to its empty position, i.e., the position allowing water to flow from conduit 60 to conduit 70 and thence back to water reservoir 72 through 74. The pump 69 will empty until a pressure of less than the illustrative minus 15 mm Hg is sensed. At that time the and-gate" 64 will no longer sense the required signal from sensor 62, and the pump 69 will be turned off and valve 56 will return to its off position.
It is noted that the above-described filling and emptying operations are generally used at the beginning and ending of use and not as continuous control means. Nevertheless it is emphasized that the ability to fill the bladder to a particular pre-determined pressure by automatic means rather than judgement means is highly advantageous.
During operation of the apparatus, the pressure within bladder 34 is maintained at its desired level by adding or removing water from the bladder system as follows:
A displacement sensing type transducer 76 is" mounted on hydraulically-actuated rod .78. Transducer 76 is adapted to provide an electrical signal output pro-.
portional to the linear advance of rod 78 at any given moment.
A normalized value of the position of rod 78 is provided by feeding the signal from transducer 76 intoa by numeral 415 in FIGS. 3 and 4.) Thus when the R wave periodically occurs with each heartbeat, an output is triggered which is fed to a manually controlled delay 86. The purpose of delay 86 is to convert the original signal from first trigger generator 84 to a second time-delayed signal corresponding in real time with the beginning of cardiac diastole. This second signal enters a duration signal generator 88. Generator 88 is so selected that the signal therefrom continues for the length of time that leg pressurization (as caused by pressure in bladder 34) is desired. This signal from generator 88 is fed to level comparator 82 through a level strobe signal generator 89.
The signal from generator 88 is also fed to a waveform generator 90 which produces a wave whose amplitude and shape is analogous to that desired for the leg pressurization sequence. A typical such wave will be trapazoidal-like in shape with a rise of 60 ms, a plateau of 250 ms, and a fall of 60 ms. This wave from generator 90 is fed to a wave form comparator 92 wherein it is continually compared to a signal derived from the actual bladder pressure wave as experienced by sensor 34. The output of comparator 92 is a so-called error signal, i.e., a signal which is indicative of the quality and strength of the difference between the desired wave signal from generator 90 and the actual wave signal from sensor 34.
It is to be noted in reference to waveform generator 90 that a typical generated wave will normally have a total positive pressure period of from about 250 to about 300 milliseconds. The rise and fall in pressure will take about 60 ms each and rise will start about 80 ms before diastole. In general, it is desirable to select a period-determining device which can maintain positive-pressure periods of up to about 500 ms.
The error signal is used to control servo valve 94 through a servo-amplifier 93 and thereby controls the supply of fluid to, and consequently the movement of, hydraulic cylinder 78.
As has been described above, level comparator 82 receives two signals: one, a periodic signal from a duration signal generator 88, via strobe signal generator 89 and the other from displacement level sensor 80. lever comparator 82 compares these two signals, one indicative of the actual position of hydraulic cylinder 78 at a given time. It is the periodic, or strobe signal from duration signal generator 88, as modified by a level strobe signal generator 89, which determines when this comparison is to be made. The comparison is most usefully made at the time platen 30 is in the upper-most portion of its stroke and pressing firmly against bladder 22.
If level comparator 82 senses that the uppermost position of platen 30 is too high, output signal is provided to a one shot (monostable multivibrator) 96. This one shot 96 will then turn on fill pump 52 and also position solenoid valve 56 for a 0.5-second fill period. The 0.5-second fill periods will continue during each cardiac period, (i.e., each heartbeat) until the water volume in bladder 22 is sufficient so that the uppermost position of platen 30 is within an acceptable displacement range at the top of its stroke.
If, on the other hand, the level comparator 82 receives a signal that the uppermost position of platen 30 is too low in its stroke, the uppermost position of empty pump is turned on for one-half second on each cardiac cycle by activation of the one shot device 98 and the empty pump 69. Water is then pumped out of the bladder until the platen achieves a desired rise during its stroke.
The general operation of the system described above is known in the art but is believed to be desirably set forth herein to fully describe the nature of the improved apparatus subject of the invention and the manner in which the operation is phased into correct synchronization with the heartbeat as described below:
A signal from any given arterial pressure-sensing device 99 is fed into a dual trace oscilloscope 101 along with a signal from ECG device 102. These signals appear only as width intensifications 103 of ECG trace 104 and the arterial trace 106.
Before discussing the processing of the ECG and arterial wave signals with respect to the oscilloscope, attention is called to FIG. 3 which shows the relative real timing of the cardiac cycle as represented by electrocardiogram 402, radial arterial pressure waveform 407, and the curve 404, representing the leg pressure rise 405 exerted by the external circulatory assist device on legs of a patient.
The electrocardiograph is characterized by R wave 415, sometimes called a QRS complex, and a T wave 420 see FIG. 4. The beginning of systole is manifested at 399 or about 40 ms after the R wave peak 415. A radial arterial sensing of this heart action will provide a waveform representative of the heart cycle; however, the precise time at which the arterial waveform is sensed, as shown in FIG. 4, will be out of phase with the ECG signal itself by a time dependent on the particular site at which the arterial waveform is sensed. Moreover, a modified waveform, and not the arterial waveform itself, will be sensed at the radial arterial sites. These modified arterial waveforms are characterized by a so-called dicrotic notch 409 which is a manifestation of the beginning of diastole in the cardiac cycle.
In the apparatus described above and known in the prior art, the external assist pressurization, for example at the legs, was to occur at a time (D,) after the triggering signal; milliseconds later the pressure wave reached the heart and after more milliseconds it was sensed at the wrist, the pre-selected sensing site. Thus, the external pressure wave became effective at the heart at the start of diastole as desired. This time corresponds, with reference to an arterial waveform, to the appearance of dicrotic notch 409 on the arterial waveform at the wrist and the apparatus was designed to initiate the pressure pulse at the legs at a time equal to seconds before the manifestation of diastole at the wrist.
A signal from an arterial pressure-sensing device 99 was fed into a dual trace oscilloscope 101 along with a signal from ECG device 102. The duration of an intensification of these signals was the duration of a pressure command signal as receiyed from druation signal gen: erator 88 and appeared as intensifications of ECG trace 104 and arterial trace 106. Delay devices of 90 milliseconds and 80 milliseconds respectively, caused the pressure command signal to appear on both waveforms in approximately correct time relationship referenced to the actual ECG and arterial pressure. D, i.e., variable delay 86 was used to bring the intensification signal into register with the diastolic period as viewed on either the ECG or arterial traces, thereby simultaneously phasing the pressurization wave to the cardiac cycle.
The operator of the apparatus also has variable control means for changing the characteristics of the duration signal generator 88 to provide the intensified signal duration which is required for a particular patient. On the oscilloscope 100, this duration showed up as intensifications 103 of the oscilloscope traces.
This prior control system depended for optimum operation on the pre-selection of a particular arterialsensing site, such as the wrist, which would typically be about 90 milliseconds out of phase with the ECG cycle.
In order to make it possible to avoid pre-selection of a given delay such as the aforesaid 90 milliseconds between the ECG event and the sensing thereof at the wrist, the following system is utilized:
A signal from an ECG device 102 is fed through a trigger generator 84, delay 86, and duration signal generator 88, into an 80 ms delay device 110 as before. The output from device 110, a pulse equal in duration to D is delayed from the R wave by a time D (imparted by delay 86) plus 80 milliseconds. This pulse is used to provide the ECG (Channel 1) intensification.
The pulse is also fed into variable delay device 112, from which-a signal is obtained which is delayed from the R wave by a time equalling D plus 80 milliseconds plus D wherein D is the variable delay imparted by adjustable delay device 112. i
The trigger signal from trigger generator 84, meanwhile, is being fed to a 40-millisecond delay device 114, and thence to a variable delay device 116. The output from device 116 is fed to a marker generator 118, which generates a marker pulse delayed from the R wave by D plus 40 milliseconds wherein D is the variable delay imparted by adjustable delay device 116. The signals from marker generator 118 and delay device 112 are fed into pulse mixer 120 and the resulting signal is fed to the channel 2 trace of the oscilloscope, i.e., that channel showing the arterial waveform.
In operation, a marker pip from generator 118, and illustrated alternatively as 414, 415 or 416 on FIG. 4, depending on the placement of the arterial sensor 99, is moved along arterial trace 106 to a position which is at the start of systole, e.g., as shown at 414. This position is characterized by the start of a fast rise 403 in the arterial trace.
The marker pip can be moved by use of marker position control 122 throughout a range equivalent to the D variable time delay simultaneously achievable with delay devices 112 and 116. As the marker pip is so moved, the intensified trace provided by duration generator 86 and representative of the external assist pressure stroke follows the marker pip but is delayed by an amount D less 40 milliseconds from the marker pip.
In use, the operator of the apparatus will first look at the arterial trace and adjust marker position control 122 and move the marker pip to its desired position, indicative of the start of systole. This time is equal to 40 milliseconds plus the delay imparted by variable delay device 1 16. Next variable delay device 86, i.e., D will be set by adjusting delay control 124 to bring the intensification signal into register with the dicrotic notch, thereby adjusting the time between notch and the intensification signal to a time represented in FIG. 4 by D Finally duration generator 88 is set by adjusting duration control 126 to give the proper pulse length, i.e., as shown by numerals 410, 411, 412 and 413 for ECG,
Central Aorta, radial artery and finger plethysmograph,
respectively, thereby phasing the pressurization wave to the cardiac cycle.
It is also to be understood that the following claims are intended to cover all of the generic and specific features of the invention herein described and all statements of the scope of the invention which might be said to fall therebetween.
What is claimed is:
L'In an external circulatory assist apparatus comprising means to pressurize a portion of a patients body, means to synchronize actuation of said pressurization means on a portion of the body with the heart cycle of a patient being treated, means for creating an arterial waveforms signal representative of said heart cycle, and display means for monitoring a said waveform signal exhibiting a dicrotic notch portion representative of said heart cycle in the form of visible traces on said display means the improvement wherein said synchronizing means includes:
A. means to provide first and second intensified marker pips on said display means displaying a marker trace representative of said arterial waveform derived from a patient,
B. a first means to adjust the position of said first marker pip relative to and along said waveform to a characteristic and identifiable position of arterial waveforms, said adjusting means also forming,
C. means to, concurrently with the adjustment of said first marker pip, move a second intensified pip along said waveform at a constant distance from said first marker, and
D. A second independent adjusting means to bring said intensified trace into register with the dicrotic notch of said waveform, said first and second adjusting means for moving said trace pips further forming variable-time adjusting means and synchronization means between a patients heart cycle and the start of said pressurization of his body.
2. Apparatus as defined in claim 1 wherein said means to provide said second said intensified marker pip comprises means to form an ECG-derived signal, a signal generator, means for triggering said signal generator by said ECG-derived signal, a variable delay means, a marker pip generator, and a pulse mixer for integrating said second marker pip signal with a signal representative of a pressure wave exerted by said external assist apparatus on said patient.
3. Apparatus as described in claim 2 wherein said variable delay means provides a delay variable over a time difference at least equal to the time elapsing from diastole in a patients heart cycle to the time such diastole is registered in said patients digital extremities.
4. Apparatus as defined in claim 1 wherein said position adjusting means provide means to adjust said marker pip over a portion of the waveform equivalent in length to time elapsing from diastole in a patients heart cycle to the time such diastole is registered in said patients digital extremities.
5. In apparatus for applying external pressure assist action to the limbs of a patient in cyclic synchronization with the heartbeat of said patient, wherein said assist is achieved with means for transmitting pressure to said limbs through a fluid-filled bladder pressurizing means surrounding said limbs, means for creating an arterial waveform signal representative of said heartbeat and display means for monitoring a said waveform signal representative of said hearbeat in the form of visible traces on said display means, wherein the apparatus also includes a visual cycle-phasing monitor comprising:
A. a multi-channel display means for displaying 1. an ECG trace, and 2. a trace derived from an arterial pressure sensor,
B. means for visually displaying for the relative time duration of a pressure command signal on said traces, and
C. manual means to adjust the relative timing and duration of said pressure command signal, while simultaneously achieving a visual adjustment of said signal to bring it into the desired relationship to said ECG trace or arterial trace; and means to initi ate said pressure command signal; and wherein said apparatus comprises:
A. means to provide a first marker pip on display apparatus displaying a marker trace representative of a radial arterial waveform derived from a patient,
B. means to adjust the position of said marker pip relative to said waveform to a characteristic and identifiable configuration of arterial waveforms, said adjusting means also forming,
C. means to, form an intensified trace on said waveform,
D. means to move, concurrently with said adjusting, an intensified trace along said waveform at a constant distance from said first marker, and
E. means to bring said intensified trace into register with the dicrotic notch of said waveform, thereby adjusting the synchronization for activating said pressure command signal.
6. In apparatus for applying external pressure assist action to the limbs of a patient in cyclic synchronization with the heartbeat of said patient, wherein said apparatus comprises means for producing a pressure command signal, means for transmitting pressure through a hydraulic cylinder to said limbs through a fluid-filled bladder pressurizing means surrounding said limbs in response to means for activating said pressure command signal, and means for creating an arterial waveform signal representative of said heartbeat and display means for monitoring a said waveform signal representative of said heartbeat in the form of visible traces on said display means, and wherein the apparatus includes A. an ideal pressure waveform generator means,
B. actual limb pressure waveform sensing means,
C. said display means forming means for continually comparing said ideal and actual waveforms, and
D. variable valve means, responsible to a signal from said comparing means, to modify fluid flow to said hydraulic cylinder and thereby to transmit pressure to said limbs through said fluid-filled bladder more nearly achieve said ideal-pressure waveform at said limbs the improvement wherein said apparatus comprises:
A. means to provide a first marker pip on display apparatus displaying a marker trace representative of said arterial waveform derived from a patient,
B. means to adjust the position of said marker pip relative to said waveform to a characteristic and identifiable configuration of arterial waveforms, said adjusting means also forming,
C. means to, form an intensified trace on said waveform,
D. means to move, concurrently with said adjusting, an intensified trace along said waveform at a constant distance from said first marker, and
E. means to bring said intensified trace into register with the dicrotic notch of said waveform, thereby adjusting the synchronization for activating said pressure command signal.
7. Apparatus as defined in claim 6 comprising: A. a multi-channel oscillosopce adapted to display 1. an ECG trace, and
2. a trace derived from an arterial pressure sensor,
B. means for visually displaying of the relative time duration of a pressure command signal on said traces, and
C. manual means to adjust the relative timing and duration of said pressure command signal, while simultaneously achieving a visual adjustment of said signal to bring it into the desired relationship to said ECG trace.
8. In a process for synchronizing a pulsed pressurizing action of an external pressure circulatory assist apparatus with the heartbeat cycle of a patient being treated with said apparatus, said process including the steps of using a display means exhibiting a trace derived from an arterial pressure sensor as a means to judge when said pressurizing action is to be initiated, the improvement comprising the steps of 1. adjusting a reference pip on said arterial trace display means to that portion of said arterial trace which is indicative of the start of the systole rise,
2. simultaneously positioning a second marker pip representative of the time and duration of said pressurization action on said arterial trace proximate and dicrotic notch portion of said trace so that said second pip coincides with the dicrotic notch of said arterial trace, and simultaneously adjusting, through setting a variable time delay means, the synchronization of a patients heartbeat with said pulsed pressurizing action, and
3. adjusting the pulse time of said pressurization action by operating a duration control means which simultaneously expands the second marker pip to form a visual representation of the pulse time on said arterial trace.

Claims (12)

1. In an external circulatory assist apparatus comprising means to pressurize a portion of a patients body, means to synchronize actuation of said pressurization means on a portion of the body with the heart cycle of a patient being treated, means for creating an arterial waveforms signal representative of said heart cycle, and display means for monitoring a said waveform signal exhibiting a dicrotic notch portion representative of said heart cycle in the form of visible traces on said display means the improvement wherein said synchronizing means includes: A. means to provide first and second intensified marker pips on said display means displaying a marker trace representative of said arterial waveform derived from a patient, B. a first means to adjust the position of said first marker pip relative to and along said waveform to a characteristic and identifiable position of arterial waveforms, said adjusting means also forming, C. means to, concurrently with the adjustment of said first marker pip, move a second intensified pip along said waveform at a constant distance from said first marker, and D. A second independent adjusting means to bring said intensified trace into register with the dicrotic notch of said waveform, said first and second adjusting means for moving said trace pips further forming variable-time adjusting means and synchronization means between a patients heart cycle and the start of said pressurization of his body.
2. Apparatus as defined in claim 1 wherein said means to provide said second said intensified marker pip comprises means to form an ECG-derived signal, a signal generator, means for triggering said signal generator by said ECG-derived signal, a variable delay means, a marker pip generator, and a pulse mixer for integrating said second marker pip signal with a signal representative of a pressure wave exerted by said external assist apparatus on said patient.
2. a trace derived from an arterial pressure sensor, B. means for visually displaying for the relative time duration of a pressure command signal on said traces, and C. manual means to adjust the relative timing and duration of said pressure command signal, while simultaneously achieving a visual adjustment of said signal to bring it into the desired relationship to said ECG trace or arterial trace; and means to initiate said pressure command signal; and wherein said apparatus comprises: A. means to provide a first marker pip on display apparatus displaying a marker trace representative of a radial arterial waveform derived from a patient, B. means to adjust the position of said marker pip relative to said waveform to a characteristic and identifiable configuration of arterial waveforms, said adjusting means also forming, C. means to, form an intensified trace on said waveform, D. means to move, concurrently with said adjusting, an intensified trace along said waveform at a constant distance from said first marker, and E. means to bring said intensified trace into register with the dicrotic notch of said waveform, thereby adjusting the synchronization for activating said pressure command signal.
2. a trace derived from an arterial pressure sensor, B. means for visually displaying of the relative time duration of a pressure command signal on said traces, and C. manual means to adjust the relative timing and duration of said pressure command signal, while simultaneously achieving a visual adjustment of said signal to bring it into the desired relationship to said ECG trace.
2. simultaneously positioning a second marker pip representative of the time and duration of said pressurization action on said arterial trace proximate and dicrotic notch portion of said trace so that said second pip coincides with the dicrotic notch of said arterial trace, and simultaneously adjusting, through setting a variable time delay means, the synchronization of a patient''s heartbeat with said pulsed pressurizing action, and
3. adjusting the pulse time of said pressurization action by operating a duration control means which simultaneously expands the second marker pip to form a visual representation of the pulse time on said arterial trace.
3. Apparatus as described in claim 2 wherein said variable delay means provides a delay variable over a time difference At least equal to the time elapsing from diastole in a patient''s heart cycle to the time such diastole is registered in said patient''s digital extremities.
4. Apparatus as defined in claim 1 wherein said position adjusting means provide means to adjust said marker pip over a portion of the waveform equivalent in length to time elapsing from diastole in a patient''s heart cycle to the time such diastole is registered in said patient''s digital extremities.
5. In apparatus for applying external pressure assist action to the limbs of a patient in cyclic synchronization with the heartbeat of said patient, wherein said assist is achieved with means for transmitting pressure to said limbs through a fluid-filled bladder pressurizing means surrounding said limbs, means for creating an arterial waveform signal representative of said heartbeat and display means for monitoring a said waveform signal representative of said hearbeat in the form of visible traces on said display means, wherein the apparatus also includes a visual cycle-phasing monitor comprising: A. a multi-channel display means for displaying
6. In apparatus for applying external pressure assist action to the limbs of a patient in cyclic synchronization with the heartbeat of said patient, wherein said apparatus comprises means for producing a pressure command signal, means for transmitting pressure through a hydraulic cylinder to said limbs through a fluid-filled bladder pressurizing means surrounding said limbs in response to means for activating said pressure command signal, and means for creating an arterial waveform signal representative of said heartbeat and display means for monitoring a said waveform signal representative of said heartbeat in the form of visible traces on said display means, and wherein the apparatus includes A. an ideal pressure waveform generator means, B. actual limb pressure waveform sensing means, C. said display means forming means for continually comparing said ideal and actual waveforms, and D. variable valve means, responsible to a signal from said comparing means, to modify fluid flow to said hydraulic cylinder and thereby to transmit pressure to said limbs through said fluid-filled bladder more nearly achieve said ideal-pressure waveform at said limbs the improvement wherein said apparatus comprises: A. means to provide a first marker pip on display apparatus displaying a marker trace representative of said arterial waveform derived from a patient, B. means to adjust the position of said marker pip relative to said waveform to a characteristic and identifiable configuration of arterial waveforms, said adjusting means Also forming, C. means to, form an intensified trace on said waveform, D. means to move, concurrently with said adjusting, an intensified trace along said waveform at a constant distance from said first marker, and E. means to bring said intensified trace into register with the dicrotic notch of said waveform, thereby adjusting the synchronization for activating said pressure command signal.
7. Apparatus as defined in claim 6 comprising: A. a multi-channel oscillosopce adapted to display
8. In a process for synchronizing a pulsed pressurizing action of an external pressure circulatory assist apparatus with the heartbeat cycle of a patient being treated with said apparatus, said process including the steps of using a display means exhibiting a trace derived from an arterial pressure sensor as a means to judge when said pressurizing action is to be initiated, the improvement comprising the steps of
US00300290A 1972-10-24 1972-10-24 Cardiac synchronization system and method Expired - Lifetime US3835845A (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
US00300290A US3835845A (en) 1972-10-24 1972-10-24 Cardiac synchronization system and method
JP48044268A JPS586502B2 (en) 1972-10-24 1973-04-20 Gaiatsujiyunkanenjiyosouchi

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US00300290A US3835845A (en) 1972-10-24 1972-10-24 Cardiac synchronization system and method

Publications (1)

Publication Number Publication Date
US3835845A true US3835845A (en) 1974-09-17

Family

ID=23158488

Family Applications (1)

Application Number Title Priority Date Filing Date
US00300290A Expired - Lifetime US3835845A (en) 1972-10-24 1972-10-24 Cardiac synchronization system and method

Country Status (2)

Country Link
US (1) US3835845A (en)
JP (1) JPS586502B2 (en)

Cited By (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4016871A (en) * 1975-03-06 1977-04-12 Peter Schiff Electronic synchronizer-monitor system for controlling the timing of mechanical assistance and pacing of the heart
US4077402A (en) * 1976-06-25 1978-03-07 Benjamin Jr J Malvern Apparatus for promoting blood circulation
US4094310A (en) * 1976-10-04 1978-06-13 American Optical Corporation Apparatus for enhanced display of physiological waveforms and for defibrillation
US4204524A (en) * 1977-11-07 1980-05-27 Dov Jaron Method and apparatus for controlling cardiac assist device
EP0081051A1 (en) * 1981-11-25 1983-06-15 Dornier Gmbh Releasing device for shock waves for therapeutic purposes
US4388919A (en) * 1980-11-17 1983-06-21 Intermedics Cardiassist Corporation Rapid stabilization of external cardiac pulsation
US4506658A (en) * 1982-01-11 1985-03-26 Casile Jean P Pericardiac circulatory assistance device
WO1989009041A1 (en) * 1988-03-31 1989-10-05 Cardiopulmonary Corporation Circulatory assist method and apparatus
US5000164A (en) * 1989-06-26 1991-03-19 The United States Of America As Represented By The Secretary Of The Navy Circulation enhancing apparatus
EP0514204A1 (en) * 1991-05-15 1992-11-19 Lcr Holding Company, Inc. Apparatus fo cyclically applying pressure to a body part
US5279283A (en) * 1992-08-11 1994-01-18 Dillon Richard S Method for promoting circulation of blood
US5377671A (en) * 1991-04-26 1995-01-03 Cardiopulmonary Corporation Cardiac synchronous ventilation
US5443440A (en) * 1993-06-11 1995-08-22 Ndm Acquisition Corp. Medical pumping apparatus
US5514079A (en) * 1992-08-11 1996-05-07 Dillon; Richard S. Method for promoting circulation of blood
US5554103A (en) * 1992-05-07 1996-09-10 Vasomedical, Inc. High efficiency external counterpulsation apparatus and method for controlling same
US5769801A (en) * 1993-06-11 1998-06-23 Ndm Acquisition Corp. Medical pumping apparatus
US5840049A (en) * 1995-09-07 1998-11-24 Kinetic Concepts, Inc. Medical pumping apparatus
WO1999036028A1 (en) 1998-01-14 1999-07-22 Cardiologic Systems, Inc. Cardiac assist method using an inflatable vest
US5931160A (en) * 1995-12-08 1999-08-03 Cardiopulmonary Corporation Ventilator control system and method
US6119043A (en) * 1995-12-28 2000-09-12 Cardiac Pacemakers, Inc. Atrial and ventricular cardiac lead having a mechanical bias
US6152954A (en) * 1998-07-22 2000-11-28 Cardiac Pacemakers, Inc. Single pass lead having retractable, actively attached electrode for pacing and sensing
US6158432A (en) * 1995-12-08 2000-12-12 Cardiopulmonary Corporation Ventilator control system and method
US6195759B1 (en) * 1997-10-20 2001-02-27 Intel Corporation Method and apparatus for operating a synchronous strobe bus
US20020107461A1 (en) * 2000-11-10 2002-08-08 Hui John C.K. High efficiency external counterpulsation apparatus and method for controlling same
US6463930B2 (en) 1995-12-08 2002-10-15 James W. Biondi System for automatically weaning a patient from a ventilator, and method thereof
US6620116B2 (en) 2000-12-08 2003-09-16 Michael P. Lewis External counterpulsation unit
US20030233118A1 (en) * 2002-06-13 2003-12-18 Hui John C. K. Method for treating congestive heart failure using external counterpulsation
EP1435892A2 (en) * 2001-09-20 2004-07-14 Living Data Technology Apparatus External counter pulsation apparatus
US20050070755A1 (en) * 1993-05-06 2005-03-31 Zhensheng Zheng High efficiency external counterpulsation method
US20050075531A1 (en) * 2003-10-07 2005-04-07 Loeb Marvin P. Devices and methods for non-invasively improving blood circulation
US6915169B2 (en) 1998-07-22 2005-07-05 Cardiac Pacemakers, Inc. Extendable and retractable lead having a snap-fit terminal connector
US6983185B2 (en) 1998-07-22 2006-01-03 Cardiac Pacemakers, Inc. Lead with terminal connector assembly
US20060058716A1 (en) * 2004-09-14 2006-03-16 Hui John C K Unitary external counterpulsation device
US7048702B2 (en) 2002-06-13 2006-05-23 Vasomedical, Inc. External counterpulsation and method for minimizing end diastolic pressure
US20070016115A1 (en) * 2005-07-04 2007-01-18 Gerhard Buchholtz Shockwave system controlled dependent on patient's blood pressure
US20070272250A1 (en) * 2006-05-24 2007-11-29 Michael Paul Lewis External pulsation treatment apparatus
US20080015478A1 (en) * 2006-07-17 2008-01-17 Arani Bose Counter pulsation system and method for stroke recovery treatment
US20080202525A1 (en) * 2007-02-23 2008-08-28 General Electric Company Setting mandatory mechanical ventilation parameters based on patient physiology
US20080202518A1 (en) * 2007-02-23 2008-08-28 General Electric Company Setting mandatory mechanical ventilation parameters based on patient physiology
US20080202519A1 (en) * 2007-02-23 2008-08-28 General Electric Company Setting mandatory mechanical ventilation parameters based on patient physiology
US20080202517A1 (en) * 2007-02-23 2008-08-28 General Electric Company Setting madatory mechanical ventilation parameters based on patient physiology
US20080202520A1 (en) * 2007-02-23 2008-08-28 General Electric Company Setting mandatory mechanical ventilation parameters based on patient physiology
US20080230064A1 (en) * 2007-03-23 2008-09-25 General Electric Company Setting inspiratory time in mandatory mechanical ventilation based on patient physiology, such as when forced inhalation flow ceases
US20080230063A1 (en) * 2007-03-23 2008-09-25 General Electric Company Setting inspiratory time in mandatory mechanical ventilation based on patient physiology, such as forced inhalation time
US20080230060A1 (en) * 2007-03-23 2008-09-25 General Electric Company Setting inspiratory time in mandatory mechanical ventilation based on patient physiology, such as when tidal volume is inspired
US20080230061A1 (en) * 2007-03-23 2008-09-25 General Electric Company Setting expiratory time in mandatory mechanical ventilation based on a deviation from a stable condition of end tidal gas concentrations
US20080319248A1 (en) * 2007-06-20 2008-12-25 Michael Paul Lewis Hydraulically Actuated External Pulsation Treatment Apparatus
US9265693B2 (en) * 2010-07-06 2016-02-23 Aleksey Monesovich Sudarev Method and devices providing impact on cardiovascular system

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3626932A (en) * 1968-10-11 1971-12-14 Hal C Becker Ekg synchronized x-ray double pulse exposure apparatus and method
US3734087A (en) * 1971-11-11 1973-05-22 Medical Innovations Inc External pressure circulatory assist

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3626932A (en) * 1968-10-11 1971-12-14 Hal C Becker Ekg synchronized x-ray double pulse exposure apparatus and method
US3734087A (en) * 1971-11-11 1973-05-22 Medical Innovations Inc External pressure circulatory assist

Cited By (81)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4016871A (en) * 1975-03-06 1977-04-12 Peter Schiff Electronic synchronizer-monitor system for controlling the timing of mechanical assistance and pacing of the heart
US4077402A (en) * 1976-06-25 1978-03-07 Benjamin Jr J Malvern Apparatus for promoting blood circulation
US4094310A (en) * 1976-10-04 1978-06-13 American Optical Corporation Apparatus for enhanced display of physiological waveforms and for defibrillation
US4204524A (en) * 1977-11-07 1980-05-27 Dov Jaron Method and apparatus for controlling cardiac assist device
US4388919A (en) * 1980-11-17 1983-06-21 Intermedics Cardiassist Corporation Rapid stabilization of external cardiac pulsation
EP0081051A1 (en) * 1981-11-25 1983-06-15 Dornier Gmbh Releasing device for shock waves for therapeutic purposes
US4685461A (en) * 1981-11-25 1987-08-11 Dornier System Gmbh Apparatus and method for triggering shock waves in lithotripsy
US4745920A (en) * 1981-11-25 1988-05-24 Dornier System Gmbh Apparatus and method for triggering therapeutic shock waves
US4506658A (en) * 1982-01-11 1985-03-26 Casile Jean P Pericardiac circulatory assistance device
US5020516A (en) * 1988-03-31 1991-06-04 Cardiopulmonary Corporation Circulatory assist method and apparatus
WO1989009041A1 (en) * 1988-03-31 1989-10-05 Cardiopulmonary Corporation Circulatory assist method and apparatus
US5000164A (en) * 1989-06-26 1991-03-19 The United States Of America As Represented By The Secretary Of The Navy Circulation enhancing apparatus
US5377671A (en) * 1991-04-26 1995-01-03 Cardiopulmonary Corporation Cardiac synchronous ventilation
EP0514204A1 (en) * 1991-05-15 1992-11-19 Lcr Holding Company, Inc. Apparatus fo cyclically applying pressure to a body part
US5396896A (en) * 1991-05-15 1995-03-14 Chrono Dynamics, Ltd. Medical pumping apparatus
US5671751A (en) * 1991-05-15 1997-09-30 Lrc Holding Company, Inc. Medical pumping apparatus
US6572621B1 (en) 1992-05-07 2003-06-03 Vasomedical, Inc. High efficiency external counterpulsation apparatus and method for controlling same
US5554103A (en) * 1992-05-07 1996-09-10 Vasomedical, Inc. High efficiency external counterpulsation apparatus and method for controlling same
US5279283A (en) * 1992-08-11 1994-01-18 Dillon Richard S Method for promoting circulation of blood
US5514079A (en) * 1992-08-11 1996-05-07 Dillon; Richard S. Method for promoting circulation of blood
US20050070755A1 (en) * 1993-05-06 2005-03-31 Zhensheng Zheng High efficiency external counterpulsation method
US5443440A (en) * 1993-06-11 1995-08-22 Ndm Acquisition Corp. Medical pumping apparatus
US5769801A (en) * 1993-06-11 1998-06-23 Ndm Acquisition Corp. Medical pumping apparatus
US5931797A (en) * 1993-06-11 1999-08-03 Kinetic Concepts, Inc. Medical pumping apparatus
US5840049A (en) * 1995-09-07 1998-11-24 Kinetic Concepts, Inc. Medical pumping apparatus
US7017574B2 (en) 1995-12-08 2006-03-28 Cardiopulmonary Corporation System for automatically weaning a patient from a ventilator, and method thereof
US6158432A (en) * 1995-12-08 2000-12-12 Cardiopulmonary Corporation Ventilator control system and method
US7334578B2 (en) 1995-12-08 2008-02-26 Cardiopulmonary Corporation System for automatically weaning a patient from a ventilator, and method thereof
US20050051167A1 (en) * 1995-12-08 2005-03-10 Biondi James W. System for automatically weaning a patient from a ventilator, and method thereof
US5931160A (en) * 1995-12-08 1999-08-03 Cardiopulmonary Corporation Ventilator control system and method
US6463930B2 (en) 1995-12-08 2002-10-15 James W. Biondi System for automatically weaning a patient from a ventilator, and method thereof
US6668829B2 (en) 1995-12-08 2003-12-30 Cardiopulmonary Corporation System for automatically weaning a patient from a ventilator, and method thereof
US6584973B1 (en) 1995-12-08 2003-07-01 Cardiopulmonary Corporation Ventilator control system and method
US6119043A (en) * 1995-12-28 2000-09-12 Cardiac Pacemakers, Inc. Atrial and ventricular cardiac lead having a mechanical bias
US6195759B1 (en) * 1997-10-20 2001-02-27 Intel Corporation Method and apparatus for operating a synchronous strobe bus
US6752771B2 (en) 1998-01-14 2004-06-22 Revivant Corporation Cardiac assist method using an inflatable vest
US6179793B1 (en) 1998-01-14 2001-01-30 Revivant Corporation Cardiac assist method using an inflatable vest
WO1999036028A1 (en) 1998-01-14 1999-07-22 Cardiologic Systems, Inc. Cardiac assist method using an inflatable vest
US6983185B2 (en) 1998-07-22 2006-01-03 Cardiac Pacemakers, Inc. Lead with terminal connector assembly
US8285398B2 (en) 1998-07-22 2012-10-09 Cardiac Pacemakers, Inc. Lead with terminal connector assembly
US6152954A (en) * 1998-07-22 2000-11-28 Cardiac Pacemakers, Inc. Single pass lead having retractable, actively attached electrode for pacing and sensing
US6345204B1 (en) 1998-07-22 2002-02-05 Cardiac Pacemakers, Inc. Single pass lead having retractable, actively attached electrode for pacing and sensing
US7774934B2 (en) 1998-07-22 2010-08-17 Cardiac Pacemakers, Inc. Method for making a terminal connector
US7392095B2 (en) 1998-07-22 2008-06-24 Cardiac Pacemakers, Inc. Extendable and retractable lead having a snap-fit terminal connector
US6915169B2 (en) 1998-07-22 2005-07-05 Cardiac Pacemakers, Inc. Extendable and retractable lead having a snap-fit terminal connector
US8209035B2 (en) 1998-07-22 2012-06-26 Cardiac Pacemakers, Inc. Extendable and retractable lead having a snap-fit terminal connector
US6589267B1 (en) 2000-11-10 2003-07-08 Vasomedical, Inc. High efficiency external counterpulsation apparatus and method for controlling same
US6962599B2 (en) 2000-11-10 2005-11-08 Vasomedical, Inc. High efficiency external counterpulsation apparatus and method for controlling same
US20020107461A1 (en) * 2000-11-10 2002-08-08 Hui John C.K. High efficiency external counterpulsation apparatus and method for controlling same
US7314478B2 (en) 2000-11-10 2008-01-01 Vasomedical, Inc. High efficiency external counterpulsation apparatus and method for controlling same
US6620116B2 (en) 2000-12-08 2003-09-16 Michael P. Lewis External counterpulsation unit
EP1435892A4 (en) * 2001-09-20 2008-03-05 Living Data Technology Corp External counter pulsation apparatus
EP1435892A2 (en) * 2001-09-20 2004-07-14 Living Data Technology Apparatus External counter pulsation apparatus
US7048702B2 (en) 2002-06-13 2006-05-23 Vasomedical, Inc. External counterpulsation and method for minimizing end diastolic pressure
US20030233118A1 (en) * 2002-06-13 2003-12-18 Hui John C. K. Method for treating congestive heart failure using external counterpulsation
US7244225B2 (en) 2003-10-07 2007-07-17 Cardiomedics, Inc. Devices and methods for non-invasively improving blood circulation
USRE42958E1 (en) * 2003-10-07 2011-11-22 Cardiomedics, Inc. Devices and methods for non-invasively improving blood circulation
US20050075531A1 (en) * 2003-10-07 2005-04-07 Loeb Marvin P. Devices and methods for non-invasively improving blood circulation
US20060058716A1 (en) * 2004-09-14 2006-03-16 Hui John C K Unitary external counterpulsation device
US20060058715A1 (en) * 2004-09-14 2006-03-16 Hui John C External counterpulsation device with multiple processors
US20060058717A1 (en) * 2004-09-14 2006-03-16 Hui John C K External counterpulsation device having a curvilinear bed
US20070016115A1 (en) * 2005-07-04 2007-01-18 Gerhard Buchholtz Shockwave system controlled dependent on patient's blood pressure
US8002718B2 (en) * 2005-07-04 2011-08-23 Siemens Aktiengesellschaft Shockwave system control dependent on patient's blood pressure
US20070272250A1 (en) * 2006-05-24 2007-11-29 Michael Paul Lewis External pulsation treatment apparatus
US7981066B2 (en) 2006-05-24 2011-07-19 Michael Paul Lewis External pulsation treatment apparatus
US20080015478A1 (en) * 2006-07-17 2008-01-17 Arani Bose Counter pulsation system and method for stroke recovery treatment
US20080202517A1 (en) * 2007-02-23 2008-08-28 General Electric Company Setting madatory mechanical ventilation parameters based on patient physiology
US20080202519A1 (en) * 2007-02-23 2008-08-28 General Electric Company Setting mandatory mechanical ventilation parameters based on patient physiology
US20080202525A1 (en) * 2007-02-23 2008-08-28 General Electric Company Setting mandatory mechanical ventilation parameters based on patient physiology
US20080202518A1 (en) * 2007-02-23 2008-08-28 General Electric Company Setting mandatory mechanical ventilation parameters based on patient physiology
US20080202523A1 (en) * 2007-02-23 2008-08-28 General Electric Company Setting mandatory mechanical ventilation parameters based on patient physiology
US20080202521A1 (en) * 2007-02-23 2008-08-28 General Electric Company Setting mandatory mechanical ventilation parameters based on patient physiology
US20080202522A1 (en) * 2007-02-23 2008-08-28 General Electric Company Setting mandatory mechanical ventilation parameters based on patient physiology
US20080202520A1 (en) * 2007-02-23 2008-08-28 General Electric Company Setting mandatory mechanical ventilation parameters based on patient physiology
US20080230061A1 (en) * 2007-03-23 2008-09-25 General Electric Company Setting expiratory time in mandatory mechanical ventilation based on a deviation from a stable condition of end tidal gas concentrations
US20080230060A1 (en) * 2007-03-23 2008-09-25 General Electric Company Setting inspiratory time in mandatory mechanical ventilation based on patient physiology, such as when tidal volume is inspired
US20080230063A1 (en) * 2007-03-23 2008-09-25 General Electric Company Setting inspiratory time in mandatory mechanical ventilation based on patient physiology, such as forced inhalation time
US20080230064A1 (en) * 2007-03-23 2008-09-25 General Electric Company Setting inspiratory time in mandatory mechanical ventilation based on patient physiology, such as when forced inhalation flow ceases
US20080319248A1 (en) * 2007-06-20 2008-12-25 Michael Paul Lewis Hydraulically Actuated External Pulsation Treatment Apparatus
US8114037B2 (en) 2007-06-20 2012-02-14 Michael Paul Lewis Hydraulically actuated external pulsation treatment apparatus
US9265693B2 (en) * 2010-07-06 2016-02-23 Aleksey Monesovich Sudarev Method and devices providing impact on cardiovascular system

Also Published As

Publication number Publication date
JPS4973878A (en) 1974-07-17
JPS586502B2 (en) 1983-02-04

Similar Documents

Publication Publication Date Title
US3835845A (en) Cardiac synchronization system and method
US3734087A (en) External pressure circulatory assist
US3303841A (en) Process and apparatus for pressurizing lower extremities of a patient during ventricular diastole
US5020516A (en) Circulatory assist method and apparatus
US5413110A (en) Computer gated positive expiratory pressure method
US4753226A (en) Combination device for a computerized and enhanced type of external counterpulsation and extra-thoracic cardiac massage apparatus
US5885244A (en) Synchronous, pulsatile angioplasty system
EP1019007B1 (en) Counterpulsation device using noncompressed air
US5514079A (en) Method for promoting circulation of blood
US3457909A (en) Heart augmentation system provided with means for measuring intra-arterial pressure
EP2571545B1 (en) Method and devices proposed for the impact on the cardiovascular system
US20030233061A1 (en) External counterpulsation and method for minimizing end diastolic pressure
US10398448B2 (en) Arteriovenous fistula maturation
US5279283A (en) Method for promoting circulation of blood
ATE42472T1 (en) PUMP FOR PERFUSION INTO THE CORONARY VESSELS.
GB1390813A (en) Apparatus for assisting blood circulation
JPS63503207A (en) Computerized positive pressure exhalation system
CN112754521B (en) Method and system for evaluating brain blood flow automatic regulation capability
US3452738A (en) Heart pump apparatus
KR102266836B1 (en) Blood pressure measuring device
JPS5830055B2 (en) External pressure circulation support device
US6921373B1 (en) Method and apparatus for a peripheral circulation enhancement system
JPH01297073A (en) Medical pump driver
US3674018A (en) Assisted cardiovascular circulation
RU2644927C1 (en) Method for operation of system of controlled intermittent pneumatic compression of upper and lower limbs with evaluation of vessels biomechanics

Legal Events

Date Code Title Description
AS Assignment

Owner name: INTERMEDICS CARDIASSIST, INC., 240 TARPON INN VILL

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST.;ASSIGNOR:CARDIASSIST CORPORATION;REEL/FRAME:004015/0042

Effective date: 19820528

AS Assignment

Owner name: CITIBANK, N.A., AS AGENT

Free format text: SECURITY INTEREST;ASSIGNORS:INTERMEDICS, INC.;INTERMEDICS CARDIASSIST, INC.;INTERMEDICS INTRAOCULAR, INC.;AND OTHERS;REEL/FRAME:004303/0077

Effective date: 19840726

Owner name: CHASE MANHATTAN BANK, N.A., THE

Free format text: SECURITY INTEREST;ASSIGNORS:INTERMEDICS, INC.;INTERMEDICS CARDIASSIST, INC.;INTERMEDICS INTRAOCULAR, INC.;AND OTHERS;REEL/FRAME:004303/0077

Effective date: 19840726

Owner name: TRUST COMPANY BANK

Free format text: SECURITY INTEREST;ASSIGNORS:INTERMEDICS, INC.;INTERMEDICS CARDIASSIST, INC.;INTERMEDICS INTRAOCULAR, INC.;AND OTHERS;REEL/FRAME:004303/0077

Effective date: 19840726

Owner name: BANK OF AMERICA NATIONAL TRUST AND SAVINGS ASSOCIA

Free format text: SECURITY INTEREST;ASSIGNORS:INTERMEDICS, INC.;INTERMEDICS CARDIASSIST, INC.;INTERMEDICS INTRAOCULAR, INC.;AND OTHERS;REEL/FRAME:004303/0077

Effective date: 19840726

Owner name: FIRST NATIONAL BANK OF CHICAGO, THE

Free format text: SECURITY INTEREST;ASSIGNORS:INTERMEDICS, INC.;INTERMEDICS CARDIASSIST, INC.;INTERMEDICS INTRAOCULAR, INC.;AND OTHERS;REEL/FRAME:004303/0077

Effective date: 19840726

Owner name: FIRST FREEPORT NATIONAL BANK

Free format text: SECURITY INTEREST;ASSIGNORS:INTERMEDICS, INC.;INTERMEDICS CARDIASSIST, INC.;INTERMEDICS INTRAOCULAR, INC.;AND OTHERS;REEL/FRAME:004303/0077

Effective date: 19840726

Owner name: BRAZOSPORT BANK OF TEXAS

Free format text: SECURITY INTEREST;ASSIGNORS:INTERMEDICS, INC.;INTERMEDICS CARDIASSIST, INC.;INTERMEDICS INTRAOCULAR, INC.;AND OTHERS;REEL/FRAME:004303/0077

Effective date: 19840726

AS Assignment

Owner name: CHASE COMMERCIAL CORPORATION

Free format text: SECURITY INTEREST;ASSIGNORS:INTERMEDICS, INC., A CORP. OF TEXAS;INTERMEDICS CARDIASSIST, INC., A CORP OF TX.;INTERMEDICS INTRAOCULAR, INC., A CORP. OF TEXAS;AND OTHERS;REEL/FRAME:004449/0501

Effective date: 19850703

Owner name: CITICORP MILTILEASE (SEF), INC.

Free format text: SECURITY INTEREST;ASSIGNORS:INTERMEDICS, INC.;INTERMEDICS CARDIASSIST, INC.;INTERMEDICS INTRAOCULAR, INC., A CORP. OF TEXAS;AND OTHERS;REEL/FRAME:004452/0900

Effective date: 19850703

Owner name: B.A. LEASING CORPORATION

Free format text: SECURITY INTEREST;ASSIGNORS:INTERMEDICS, INC., A CORP. OF TEXAS;INTERMEDICS CARDIASSIST, INC.;INTERMEDICS INTRAOCULAR, INC., A CORP. OF TEXAS;AND OTHERS;REEL/FRAME:004449/0424

Effective date: 19850703

Owner name: CITIBANK, N.A.

Free format text: SECURITY INTEREST;ASSIGNORS:INTERMEDICS, INC., A TX CORP;INTERMEDICS CARDIASSIST, INC., A TX CORP.;INTERMEDICS INTRAOCULAR, INC., A TX CORP.;AND OTHERS;REEL/FRAME:004434/0728

Effective date: 19850703

AS Assignment

Owner name: INTERMEDICS, INC., INTERMEDICS CARDIASSIST, INC.,

Free format text: SECURED PARTY HEREBY RELEASE THE SECURITY INTEREST IN AGREEMENT RECORDED AUGUST 5, 1985. REEL 4434 FRAMES 728-782;ASSIGNOR:CITIBANK, N.A.;REEL/FRAME:004592/0394

Effective date: 19860502

Owner name: INTERMEDICS, INC., INTERMEDICS CARDIASSIST, INC.,

Free format text: SAID PARTIES RECITES OBLIGATIONS RECITED IN SECURITY AGREEMENT RECORDED SEPTEMBER 17, 1984 REEL 4303 FRAMES 077-127 HAVE BEEN PAID IN FULL ALL;ASSIGNOR:CITIBANK, N.A., INDIVIDUALLY AND AS AGENT FOR BANK OF AMERICA NATIONAL TRUST AND SAVINGS ASSOCIATION, THE CHASE MANHATTAN BANK, N.A., THE FIRST NATIONAL BANK OF CHICAGO, TRUST COMPANY BANK, FIRST FREEPORT NATIONAL BANK OF BRAZOSPORT BANK OF TEXAS;REEL/FRAME:004592/0424

Effective date: 19860502

Owner name: INTERMEDICS, INC.

Free format text: RELEASED BY SECURED PARTY;ASSIGNOR:CITICORP MULTILEASE (SEF), INC.;REEL/FRAME:004576/0516

Effective date: 19860515

AS Assignment

Owner name: MAY PARTNERSHIP THE, 2170 PIEDMONT ROAD, N.E., ATL

Free format text: SECURITY INTEREST;ASSIGNORS:INTERMEDICS, INC.,;INTERMEDICS CARDIASSIST, INC.;SURGITRONICS CORPORATION;AND OTHERS;REEL/FRAME:004581/0501

Effective date: 19860703

Owner name: MAY PARTNERSHIP, THE,GEORGIA

Free format text: SECURITY INTEREST;ASSIGNORS:INTERMEDICS, INC.,;INTERMEDICS CARDIASSIST, INC.;SURGITRONICS CORPORATION;AND OTHERS;REEL/FRAME:004581/0501

Effective date: 19860703

AS Assignment

Owner name: INTERMEDICS, INC., A TEXAS CORP.

Free format text: RELEASED BY SECURED PARTY;ASSIGNOR:B. A. LEASING CORPORATION;REEL/FRAME:004603/0607

Effective date: 19860813

Owner name: INTERMEDICS CARDIASSIST, INC., A TEXAS CORP.

Free format text: RELEASED BY SECURED PARTY;ASSIGNOR:B. A. LEASING CORPORATION;REEL/FRAME:004603/0607

Effective date: 19860813

Owner name: INTERMEDICS INTRAOCULAR, INC., A TEXAS CORP.

Free format text: RELEASED BY SECURED PARTY;ASSIGNOR:B. A. LEASING CORPORATION;REEL/FRAME:004603/0607

Effective date: 19860813

Owner name: SURGITRONICS CORPORATION, A TEXAS CORP.

Free format text: RELEASED BY SECURED PARTY;ASSIGNOR:B. A. LEASING CORPORATION;REEL/FRAME:004603/0607

Effective date: 19860813

Owner name: CARBOMEDICS, INC., A TEXAS CORP.

Free format text: RELEASED BY SECURED PARTY;ASSIGNOR:B. A. LEASING CORPORATION;REEL/FRAME:004603/0607

Effective date: 19860813

Owner name: NEUROMEDICS, INC., A TEXAS CORP.

Free format text: RELEASED BY SECURED PARTY;ASSIGNOR:B. A. LEASING CORPORATION;REEL/FRAME:004603/0607

Effective date: 19860813

Owner name: CALCITEK, INC., A TEXAS CORP.

Free format text: RELEASED BY SECURED PARTY;ASSIGNOR:B. A. LEASING CORPORATION;REEL/FRAME:004603/0607

Effective date: 19860813

Owner name: AMERICAN PACEMAKER CORPORATION, A MASSACHUSETTS CO

Free format text: RELEASED BY SECURED PARTY;ASSIGNOR:B. A. LEASING CORPORATION;REEL/FRAME:004603/0607

Effective date: 19860813

Owner name: INTERMEDICS, INC.

Free format text: RELEASED BY SECURED PARTY;ASSIGNOR:CHASE COMMERCIAL CORPORATION;REEL/FRAME:004605/0581

Effective date: 19860804

Owner name: INTERMEDICS CARDIASSIST, INC.

Free format text: RELEASED BY SECURED PARTY;ASSIGNOR:CHASE COMMERCIAL CORPORATION;REEL/FRAME:004605/0581

Effective date: 19860804

Owner name: INTERMEDICS INTRAOCULAR, INC.

Free format text: RELEASED BY SECURED PARTY;ASSIGNOR:CHASE COMMERCIAL CORPORATION;REEL/FRAME:004605/0581

Effective date: 19860804

Owner name: SURGITRONICS CORPORATION

Free format text: RELEASED BY SECURED PARTY;ASSIGNOR:CHASE COMMERCIAL CORPORATION;REEL/FRAME:004605/0581

Effective date: 19860804

Owner name: CARBO-MEDICS, INC.

Free format text: RELEASED BY SECURED PARTY;ASSIGNOR:CHASE COMMERCIAL CORPORATION;REEL/FRAME:004605/0581

Effective date: 19860804

Owner name: NEUROMEDICS, INC.

Free format text: RELEASED BY SECURED PARTY;ASSIGNOR:CHASE COMMERCIAL CORPORATION;REEL/FRAME:004605/0581

Effective date: 19860804

Owner name: CALCITEK, INC., ALL TEXAS CORPS

Free format text: RELEASED BY SECURED PARTY;ASSIGNOR:CHASE COMMERCIAL CORPORATION;REEL/FRAME:004605/0581

Effective date: 19860804

Owner name: AMERICAN PACEMAKER CORPORATION A CORP OF MA

Free format text: RELEASED BY SECURED PARTY;ASSIGNOR:CHASE COMMERCIAL CORPORATION;REEL/FRAME:004605/0581

Effective date: 19860804

Owner name: INTERMEDICS, INC., A TEXAS CORP., STATELESS

Free format text: RELEASED BY SECURED PARTY;ASSIGNOR:B. A. LEASING CORPORATION;REEL/FRAME:004603/0607

Effective date: 19860813

Owner name: INTERMEDICS CARDIASSIST, INC., A TEXAS CORP., STAT

Free format text: RELEASED BY SECURED PARTY;ASSIGNOR:B. A. LEASING CORPORATION;REEL/FRAME:004603/0607

Effective date: 19860813

Owner name: INTERMEDICS INTRAOCULAR, INC., A TEXAS CORP., STAT

Free format text: RELEASED BY SECURED PARTY;ASSIGNOR:B. A. LEASING CORPORATION;REEL/FRAME:004603/0607

Effective date: 19860813

Owner name: SURGITRONICS CORPORATION, A TEXAS CORP., STATELESS

Free format text: RELEASED BY SECURED PARTY;ASSIGNOR:B. A. LEASING CORPORATION;REEL/FRAME:004603/0607

Effective date: 19860813

Owner name: CARBOMEDICS, INC., A TEXAS CORP., STATELESS

Free format text: RELEASED BY SECURED PARTY;ASSIGNOR:B. A. LEASING CORPORATION;REEL/FRAME:004603/0607

Effective date: 19860813

Owner name: NEUROMEDICS, INC., A TEXAS CORP., STATELESS

Free format text: RELEASED BY SECURED PARTY;ASSIGNOR:B. A. LEASING CORPORATION;REEL/FRAME:004603/0607

Effective date: 19860813

Owner name: CALCITEK, INC., A TEXAS CORP., STATELESS

Free format text: RELEASED BY SECURED PARTY;ASSIGNOR:B. A. LEASING CORPORATION;REEL/FRAME:004603/0607

Effective date: 19860813

AS Assignment

Owner name: INTERMEDICS, INC.

Free format text: RELEASED BY SECURED PARTY;ASSIGNOR:MAY PARTNERSHIP, THE, BY: ROLLINS HOLDING COMPANY, INC.;REEL/FRAME:004874/0945

Effective date: 19870112